A proof-of-concept study: investigating the impact of COMT genotype and proline on negative symptoms in Alzheimer’s disease
James D. Clelland, Hector W. Cure, Ashley M. Canizares, Julia H. Anderson, Bimala Rawal, Sabrina A. Wong, Nancy Kerner, Edward D. Huey, Lawrence S. Honig, Devangere P. Devanand, Catherine L. Clelland · 2026
Read A proof-of-concept study: investigating the impact of COMT genotype and proline on negative symptoms in Alzheimer’s disease by James D. Clelland, Hector W. Cure, Ashley M. Canizares, Julia H. Anderson, Bimala Rawal, Sabrina A. Wong, Nancy Kerner, Edward D. Huey, Lawrence S. Honig, Devangere P. Devanand, Catherine L. Clelland (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12724090.txt.
Description
Clelland and co-authors test whether a blood amino acid and a dopamine gene variant jointly shape the flat, withdrawn symptoms of Alzheimer's disease. Earlier work in severe mental illness found the amino acid proline helped or hurt depending on which variant of the COMT gene a patient carried. Their 2025 proof-of-concept study extends the test to fifty patients with Alzheimer's or its early stage.
A sparse regression found the interaction significantly predicted symptom scores on one standard scale, with a near miss on a second scale. Higher proline went with milder symptoms in two gene groups but worse symptoms in carriers of the low-activity variant. The authors say the pattern mirrors the psychosis findings. They back drug work aimed at this pathway.
Catalog record
| CREATOR | James D. Clelland, Hector W. Cure, Ashley M. Canizares, Julia H. Anderson, Bimala Rawal, Sabrina A. Wong, Nancy Kerner, Edward D. Huey, Lawrence S. Honig, Devangere P. Devanand, Catherine L. Clelland |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 26 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |